
Misonix, Inc. Market Cap | MSON
As of September 09, 2026 Misonix, Inc. has a market cap of $ 462 M
Capitalization is the market value of a company whose shares are traded on the stock exchange. It is calculated by multiplying the market price of a share by the total number of the company's shares. Capitalization indicates volatility, risk, and growth potential. This metric is often used for a quick assessment of a company’s investment profile.[1]
Capitalization is an important indicator for investors and analysts, as it helps determine the size and significance of a company in the stock market. Companies with large capitalization are considered more stable and reliable, as they have more resources and financial power to grow and survive in the market.
This metric can be divided into several categories: small (from 300 million to 2 billion dollars), medium (from 2 to 10 billion dollars), and large (over 10 billion dollars). Companies with different levels of capitalization have their own characteristics and risks, so investors usually take this indicator into account when making investment decisions.
Capitalization can also change over time depending on the share price and the number of shares in circulation. Therefore, it is a dynamic indicator that requires constant monitoring and analysis to make well-informed investment decisions.
Annual Market Cap Misonix, Inc.
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| 185 M | 226 M | 152 M | 69.3 M | 47.4 M | 69.8 M | 48.6 M | 36.3 M | 17.4 M | 16.8 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 226 M | 16.8 M | 86.8 M |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.
Market Cap of other stocks in the Medical devices industry
| Issuer | Market Cap | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Sintx Technologies
SINT
|
6.91 M | $ 1.74 | 6.75 % | $ 4.83 M | ||
|
Smith & Nephew plc
SNN
|
27.4 B | $ 27.87 | 0.16 % | $ 24.2 B | ||
|
Stryker Corporation
SYK
|
147 B | $ 276.43 | 0.68 % | $ 106 B | ||
|
Tandem Diabetes Care
TNDM
|
1.26 B | $ 19.88 | 0.4 % | $ 1.35 B | ||
|
Sensus Healthcare
SRTS
|
72.3 M | $ 3.16 | 0.94 % | $ 51.6 M | ||
|
Viemed Healthcare
VMD
|
352 M | $ 8.79 | 0.78 % | $ 342 M | ||
|
Varex Imaging Corporation
VREX
|
502 M | $ 18.49 | 0.03 % | $ 765 M | ||
|
NuVasive
NUVA
|
2.29 B | - | - | $ 2.07 B | ||
|
Vivos Therapeutics
VVOS
|
15.1 M | $ 0.18 | 6.76 % | $ 1.85 M | ||
|
TELA Bio
TELA
|
32.4 M | $ 0.83 | 1.05 % | $ 39 M | ||
|
Beyond Air
XAIR
|
4.15 B | $ 3.38 | 0.93 % | $ 28.1 B | ||
|
Zimmer Biomet Holdings
ZBH
|
16.3 B | $ 94.22 | 0.69 % | $ 18.7 B | ||
|
Cognyte Software Ltd.
CGNT
|
591 M | $ 8.23 | 0.71 % | $ 600 M | ||
|
Axonics Modulation Technologies
AXNX
|
2.82 B | - | - | $ 3.31 B | ||
|
BIOLASE
BIOL
|
192 K | - | -13.19 % | $ 166 K | ||
|
Conformis
CFMS
|
12.6 M | - | - | $ 16.4 M | ||
|
Cutera
CUTR
|
46.5 M | - | -10.19 % | $ 1.99 M | ||
|
Eargo
EAR
|
17 M | - | - | $ 10.2 M | ||
|
Medigus Ltd.
MDGS
|
135 M | - | 10.28 % | $ 55.5 M | ||
|
Inari Medical
NARI
|
3.07 B | - | - | $ 4.23 B | ||
|
Nemaura Medical
NMRD
|
24.4 M | - | -17.8 % | $ 2.74 M | ||
|
Neovasc
NVCN
|
677 M | - | - | $ 111 M | ||
|
SmileDirectClub
SDC
|
74 M | - | -53.45 % | $ 9.71 M | ||
|
Sientra
SIEN
|
20.9 M | - | -16.59 % | $ 10.3 M | ||
|
Silk Road Medical, Inc
SILK
|
683 M | - | - | $ 1.07 B | ||
|
Surgalign Holdings
SRGA
|
11.4 M | - | -32.98 % | $ 1.68 M | ||
|
ShockWave Medical
SWAV
|
9.61 B | - | - | $ 12.3 B | ||
|
ThermoGenesis Holdings
THMO
|
2.09 M | - | -25.84 % | $ 171 K | ||
|
Talis Biomedical Corporation
TLIS
|
15.9 M | - | 3.55 % | $ 7.96 M | ||
|
Viveve Medical
VIVE
|
10.6 M | - | -15.35 % | $ 1.71 M | ||
|
ViewRay
VRAY
|
477 M | - | 1.54 % | $ 468 M | ||
|
Titan Medical
TMDI
|
115 M | - | -26.32 % | $ 19.6 M | ||
|
Natus Medical Incorporated
NTUS
|
799 M | - | 1.94 % | $ 1.05 B | ||
|
Acutus Medical
AFIB
|
5.24 M | - | -26.83 % | $ 2.62 M | ||
|
Cardiovascular Systems
CSII
|
602 M | - | 0.15 % | $ 844 M | ||
|
Invacare Corporation
IVC
|
24.1 M | - | - | $ 24.7 M | ||
|
GenMark Diagnostics, Inc.
GNMK
|
933 M | - | - | $ 1.77 B | ||
|
Lianluo Smart Limited
LLIT
|
147 M | - | 24.59 % | $ 44.8 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
35 M | - | -5.86 % | $ 30.6 M | ||
|
Profound Medical Corp.
PROF
|
166 M | $ 6.81 | 1.32 % | $ 206 M | ||
|
Tactile Systems Technology
TCMD
|
640 M | $ 21.73 | 0.09 % | $ 497 M | ||
|
Abbott Laboratories
ABT
|
196 B | $ 105.52 | 0.03 % | $ 184 B | ||
|
Aethlon Medical
AEMD
|
1.36 M | $ 1.81 | 1.09 % | $ 1.22 M | ||
|
AdaptHealth Corp.
AHCO
|
1.2 B | $ 6.19 | 1.09 % | $ 837 M | ||
|
Align Technology
ALGN
|
12.9 B | $ 153.49 | 0.03 % | $ 11.1 B | ||
|
Apyx Medical Corporation
APYX
|
142 M | $ 3.05 | 0.33 % | $ 125 M | ||
|
Accuray Incorporated
ARAY
|
31.9 M | $ 0.26 | 0.37 % | $ 31.9 M | ||
|
Alphatec Holdings
ATEC
|
2.07 B | $ 9.19 | 1.29 % | $ 1.38 B | ||
|
AxoGen
AXGN
|
1.5 B | $ 46.69 | 2.51 % | $ 2.15 B | ||
|
Butterfly Network
BFLY
|
946 M | $ 7.52 | 2.17 % | $ 1.86 B |